Gary Nachman
Stock Analyst at BMO Capital
(0.58)
# 2019
Out of 5,253 analysts
145
Total ratings
58.46%
Success rate
6.05%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Schrodinger | Maintains: Outperform | 25 28 | 24.2 | 15.7% | 5 | Nov 13, 2024 | |
Alnylam Pharmaceutic... | Maintains: Outperform | 275 298 | 282.06 | 5.65% | 7 | Nov 1, 2024 | |
LENZ Therapeutics | Initiates Coverage On: Outperform | 37 | 25.02 | 47.88% | 1 | Sep 27, 2024 | |
Achieve Life Science... | Initiates Coverage On: Strong Buy | 20 | 3.01 | 564.45% | 1 | Sep 27, 2024 | |
Pacira BioSciences | Maintains: Outperform | 41 37 | 25.14 | 47.18% | 13 | Jul 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 19 | 17.57 | 8.14% | 1 | Jul 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 3 | 0.56 | 435.71% | 1 | Mar 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Strong Buy | 30 | 42.07 | -28.69% | 5 | Mar 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | 3.12 | 124.36% | 1 | Mar 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 1 | Mar 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 181 189 | 175.88 | 7.46% | 13 | Feb 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 11 | Sep 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 4 | 8.68 | -53.92% | 5 | Mar 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 30 | 6.25 | 380% | 4 | Mar 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 67 | 34.52 | 94.09% | 2 | Feb 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 32 | 3.28 | 875.61% | 1 | Feb 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 16 14 | 11.22 | 24.78% | 2 | Feb 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 10 | Dec 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 90 75 | 6.31 | 1088.59% | 4 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 57 35 | n/a | n/a | 3 | Nov 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 43 40 | 7.37 | 442.74% | 8 | Nov 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 11 10 | 21.58 | -53.66% | 1 | Nov 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 30 | 21.68 | 38.38% | 2 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 2 | n/a | n/a | 1 | Aug 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 810 750 | 3.01 | 24816.94% | 2 | Aug 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 15 8 | 7.74 | 3.36% | 2 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 4 2 | n/a | n/a | 5 | May 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 20 12 | n/a | n/a | 6 | Oct 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 20 21 | 36.9 | -43.09% | 4 | May 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 3 | n/a | n/a | 4 | Sep 5, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Sep 5, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 4 3 | n/a | n/a | 4 | Aug 12, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 76 32 | n/a | n/a | 3 | Aug 21, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 14 | 3.19 | 338.87% | 2 | Jun 14, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 18 20 | n/a | n/a | 2 | Apr 16, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 16 17 | n/a | n/a | 3 | Nov 13, 2017 |